603222 济民健康
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.616-3.9892.34014.0280.740
总资产报酬率 ROA (%)1.028-2.5211.3416.2550.292
投入资产回报率 ROIC (%)1.175-2.8991.5737.8250.376

边际利润分析
销售毛利率 (%)44.36842.43146.28448.04841.055
营业利润率 (%)7.475-4.9005.49115.2533.588
息税前利润/营业总收入 (%)8.976-3.3807.73819.4145.486
净利润/营业总收入 (%)6.668-5.5003.12012.568-0.789

收益指标分析
经营活动净收益/利润总额(%)91.850-53.970155.293101.1431,371.885
价值变动净收益/利润总额(%)2.012-8.39721.83220.772-85.720
营业外收支净额/利润总额(%)-5.99710.840-7.0563.972-472.847

偿债能力分析
流动比率 (X)1.5261.5711.7921.1220.833
速动比率 (X)1.2221.2871.5890.9470.711
资产负债率 (%)32.72133.07034.62143.31854.351
带息债务/全部投入资本 (%)24.97621.94326.95935.26847.306
股东权益/带息债务 (%)286.379337.061265.315176.130102.888
股东权益/负债合计 (%)194.554192.170181.662117.89169.418
利息保障倍数 (X)4.666-1.5972.9665.5001.129

营运能力分析
应收账款周转天数 (天)68.39463.18667.73960.52573.941
存货周转天数 (天)98.18487.90499.02578.65978.370